packageTrilaciclib

trilaciclib

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Trilaciclib is a kinase inhibitor used in patients with small cell lung cancer, where it acts as a detoxifying agent for antineoplastic treatment. It is an approved drug, but it is not authorised in the European Union.

Summary written by glm-5.3-flash from Wikidata Q105592965 and the WHO ATC classification; not checked by a person.

name:trilaciclib
ATC codes:V03AF12
DrugBank:DB15442
PubChem CID:68029831
Wikidata:Q105592965
formula:C24H30N8O
molar mass:446.559 g/mol (PubChem CID 68029831)
logP:2.6 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown